Table 2.
Contribution of gut microbe EVs to immune homeostasis.
| Species | Evidence from studies | Reference |
|---|---|---|
| Escherichia coli Nissle 1917 | Reduction in the expression of pro-inflammatory cytokines in colitis | Lee et al. (2012) |
| Increase in epithelial barrier integrity through the upregulation of tight junction proteins | Alvarez et al. (2016) | |
| Bacteroides fragilis | Promotion of an immunomodulatory Treg response through DCs stimulation in colitis and mucosal tolerance through the regulation of autophagic genes | Shen et al. (2012) |
| Induction and inhibition of anti-inflammatory and pro-inflammatory cytokines in the Caco-2 cell line, respectively | Ahmadi Badi et al. (2019) | |
| Lactobacillus rhamnosus | Increase in gut DC levels and the induction of IL-10 release | Al-Nedawi et al. (2015) |
| Lactobacillus sakei | Increase in IgA production in the gut and improvement in epithelial barrier function | Yamasaki-Yashiki et al. (2019) |
| Lactobacillus kefir, Lactobacillus kefiranofaceins, Lactobacillus kefirgranum | Suppression of proinflammatory cytokine production in an IBD mouse model | Seo et al. (2018) |
| Akkermansia muciniphila | Inhibition of colitis progression by improving macroscopic scores | Kang et al. (2013) |
| Promotion of AMPK phosphorylation and prevention of LPS-induced intestinal barrier damage | Chelakkot et al. (2018) | |
| Recovery of the gut barrier integrity in HFD-induced obesity by improving the expression of tight junction proteins | Chelakkot et al. (2018) | |
| Bifidobacterium longum | Improvements in allergic diarrhea through mast cells apoptosis in a food allergy mouse model | Kim et al. (2016) |
| Bifidobacterium bifidum | Promotion of an immunomodulatory Treg response through DC stimulation in PBMCs-isolated naïve T cells | López et al. (2012) |
| Bifidobacterium vulgatus | Induction of tolerance in colonic BMDCs | Maerz et al. (2018) |
DCs, dendritic cells; IL, interleukin; HFD, high-fat diet; IBD, inflammatory bowel disease; IgA, immunoglobulin A; PBMCs, peripheral blood mononuclear cells; BMDCs, Bone Marrow-Derived Dendritic Cells.